Recent evidence indicates that arrest of mammalian cells at the G 2 /M checkpoint involves inactivation and translocation of Cdc25C, which is mediated by phosphorylation of Cdc25C on serine 216. Data obtained with a phospho-specific antibody against serine 216 suggest that activation of the DNA damage checkpoint is accompanied by an increase in serine 216 phosphorylated Cdc25C in the nucleus after exposure of cells to ␥-radiation. Prior treatment of cells with 2 mM caffeine inhibits such a change and markedly reduces radiation-induced ataxia-telangiectasia-mutated (ATM)-dependent Chk2/Cds1 activation and phosphorylation. Chk2/Cds1 is known to localize in the nucleus and to phosphorylate Cdc25C at serine 216 in vitro. Caffeine does not inhibit Chk2/Cds1 activity directly, but rather, blocks the activation of Chk2/Cds1 by inhibiting ATM kinase activity. In vitro, ATM phosphorylates Chk2/Cds1 at threonine 68 close to the N terminus, and caffeine inhibits this phosphorylation with an IC 50 of approximately 200 M. Using a phospho-specific antibody against threonine 68, we demonstrate that radiation-induced, ATM-dependent phosphorylation of Chk2/Cds1 at this site is caffeinesensitive. From these results, we propose a model wherein caffeine abrogates the G 2 /M checkpoint by targeting the ATM-Chk2/Cds1 pathway; by inhibiting ATM, it prevents the serine 216 phosphorylation of Cdc25C in the nucleus. Inhibition of ATM provides a molecular explanation for the increased radiosensitivity of caffeine-treated cells.
Most effective anti-cancer therapies are genotoxic agents that damage DNA and kill dividing cells. In addition to apoptosis, DNA damage induced by ionizing radiation (IR) 1 or other insults triggers cell cycle checkpoint activation and subsequent cell cycle arrest, augmenting the ability of cells to repair damaged DNA (1, 2) . The checkpoint could contribute to the development of drug resistance, a formidable limitation in current cancer treatment, and consequently agents that override cell cycle checkpoints could be used to sensitize cells to killing by genotoxic drugs (3) . Proof of this concept has arisen from studies with caffeine, which causes the disruption of DNA damage checkpoints (including the G 2 /M checkpoint), and sensitizes tumor cells to ionizing radiation and other genotoxic agents (4, 5) . However, the mechanism of action of caffeine and its molecular targets remain unclear. One possible target is phosphodiesterase, but a more potent phosphodiesterase inhibitor, 3-isobutyl-1-methylxanthine, is unable to abrogate checkpoint function in many systems (5) , suggesting that alternative targets exist for caffeine.
For mammalian cells, arrest in G 2 phase is due largely to maintenance of inhibitory phosphorylations on Cdc2 (6) . Dephosphorylation of Cdc2 at these sites is catalyzed by the dual specificity phosphatase Cdc25 (7) (8) (9) . Recent evidence indicates that the G 2 /M DNA checkpoint involves inactivation and possibly translocation of Cdc25C into the cytoplasm akin to what has been demonstrated for fission yeast Cdc25 (10 -12) . This is at least partially mediated by phosphorylation at serine 216 in Cdc25C and is likely to involve binding of 14-3-3 proteins to this phosphorylation site (13, 14) . Expression of a Cdc25C mutant where alanine is substituted for serine 216 (S216A) induces premature entry into mitosis by overriding a ␥-radiation-induced DNA damage checkpoint (13) . During the normal progression through the cell cycle, serine 216 phosphorylation may also contribute to the negative regulation of Cdc25C because Cdc25C is phosphorylated at this site in interphase but not during mitosis when Cdc25 is active (13, 15) . cTAK1, a cytoplasmic kinase that phosphorylates Cdc25C specifically at serine 216 in vitro could be involved in the negative regulation of Cdc25C in interphase cells (16, 17) . On the other hand, the nuclear kinases Chk1 (13, 15) and Chk2/Cds1 (18 -21) , which can phosphorylate Cdc25C at serine 216 in vitro, could contribute to the maintenance of this phosphorylation in cells arrested at G 2 /M in response to DNA damage. So far, only Chk2/Cds1 kinase activity has been shown to increase dramatically in a checkpoint-dependent manner (18 -21) . However, it is still unclear how DNA damage affects Cdc25C serine 216 phosphorylation, nor do we know if inhibition of the Chk1 or Chk2/Cds1 pathways alters this phosphorylation. Accumulating data suggest that ataxia-telangiectasia-mutated (ATM) kinase is a proximal component of DNA damage-induced cell cycle checkpoint pathway (22) . ATM must play an important role in the G 2 /M checkpoint because ATM-deficient cells fail to arrest in the G 2 phase of cell cycle prior to mitosis after DNA damage (23) . It has been demonstrated that radiation-induced Chk2/ Cds1 activation is ATM-dependent (18 -21) , although it is unclear whether activation of Chk1 is also ATM-dependent. It remains to be shown that ATM directly phosphorylates Chk2/ Cds1. To study how caffeine abrogates the G 2 /M checkpoint, it will be necessary to examine how caffeine affects the known G 2 /M checkpoint signal transduction pathway involving the phosphorylation of serine 216 on Cdc25C.
We present evidence here showing that caffeine inhibits ATMdependent activation of Chk2/Cds1 in vivo. In vitro, caffeine did not inhibit Chk2/Cds1 directly but instead inhibited ATM at an IC 50 of approximately 200 M. During the preparation of this manuscript, similar findings that caffeine can inhibit ATM kinase activity were reported (24, 25) . Our study provides further mechanistic details of how this inhibition can lead to the abrogation of the G 2 /M checkpoint. Using a recently generated phospho-specific antibody against serine 216, we demonstrate that activation of the DNA damage checkpoint is correlated with an increase in serine 216-phosphorylated Cdc25C in the nucleus and further, that prior treatment of cells with caffeine inhibits such a change. In addition, we provide evidence showing that ATM phosphorylates Chk2/Cds1 at threonine 68 in the N terminus, also in a caffeine-sensitive manner. Finally, caffeine is shown to inhibit ATM-dependent Chk2/ Cds1 phosphorylation in vivo. Using a phospho-specific antibody against threonine 68, we found that Chk2/Cds1 is phosphorylated at this site in vivo in cells after IR exposure, and this phosphorylation is inhibited by prior treatment of cells with caffeine. These results are consistent with a model in which caffeine abrogates the G 2 /M checkpoint by targeting the ATM-Chk2/Cds1 pathway by inhibiting ATM.
EXPERIMENTAL PROCEDURES
Constructs and Recombinant Proteins-To make a kinase-dead Chk2, aspartic acid 347 was converted to alanine by site-directed mutagenesis. Full-length wild type and kinase-dead (KD) Chk2 (D347A) were subcloned into pFASTBAC as GST fusion protein (Invitrogen) for baculovirus expression. Recombinant Chk2-GST proteins were purified by a glutathione-Sepharose affinity step followed by a gel filtration column. Full-length kinase-dead (KD) Chk2 and threonine 68 to alanine mutant, N terminus (amino acids 1-222), and C terminus of Chk2 (amino acids 206 -543, with D347A mutation) were also subcloned into pGEX-5X for expression in bacteria and subsequently purified as GST fusion proteins as described above.
Antibodies-Phosphopeptides of the following sequence were synthesized: phospho-S216, GLYRSP-pS-MPENLNR; phospho-T68, SS-LETVS-pT-QELYS, and coupled to KLH. Phosphospecific antibodies to the KLH-coupled peptides were obtained and purified. Anti-Chk2 was described in Chaturvedi et al. (21) . Anti-ATM was purchased from Oncogene Research Products (Cambridge, MA), anti-Cdc25C (C-20) from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA), and anti-phospho-S15 of p53 from New England Biolabs (Beverly, MA).
Immunostaining-MRC-5 cells were plated in microchamber slides overnight and irradiated the next day with 20 Gy of IR and then incubated at 37°C for 30 min before fixing and staining. Untreated cells and cells processed with secondary antibody alone were included as controls. The cells were fixed for 10 min in PBS-buffered paraformaldehyde, 2% sucrose solution, followed by permeabilization for 10 min in cold buffer containing 0.5% Triton X-100 in 20 mM Hepes, pH 7.4, 3 mM MgCl 2 , 50 mM NaCl, and 300 mM sucrose (26) . They were then blocked in 3% bovine serum (BSA) in PBS-Tween 20 and incubated in primary antibody at 1:3000 dilution in PBS-BSA for 1 h at 4°C before washing three times with PBS-BSA. The slides were incubated in fluorescein isothiocyanate-labeled secondary antibody in PBS-BSA for 1 h, washed three times with PBS-BSA, twice with PBS alone, and then drymounted. The slides were seen under an inverted florescence microscope (OLYMPUS BX-60).
Extract Preparation-Whole cell extracts were prepared as described (21) . Nuclear and cytoplasmic extracts were prepared using a kit from Pierce. Cells were grown in 100-ml flasks and treated with caffeine (2 mM) overnight and irradiated with 20 Gy. They were then removed by scraping and collected by centrifugation, and the pellets were lysed in extraction buffer to obtain the cytoplasmic fractions in the supernatant. The remaining pellets containing the nuclear fraction were then washed thoroughly three times with PBS and lysed in extraction buffer to obtain the nuclear extract.
Kinase Assays-Chk2 kinase assays (21) and ATM kinase assays (27) were performed as described. ATM was immunoprecipitated by adding anti-ATM antibody to total cell lysates and incubating with protein G-Sepharose for 2 h at 4°C. Kinase assays were performed on the beads by incubating the resulting complexes in kinase buffer containing 10 mM Hepes (pH 7.5), 50 mM ␤-glycerophosphate, 50 mM NaCl, 10 mM MgCl 2 , 10 mM MnCl 2 , 1 mM dithiothreitol, 5 M ATP, 10 Ci of [ 32 P]ATP, and 1 g of substrate for 30 min at 30°C, and products were analyzed by SDS-PAGE followed by autoradiography.
RESULTS

Caffeine Abrogates the ␥-Radiation-induced Increase in Serine 216 Phosphorylation of Cdc25C in the Nucleus-It has been
established that the G 2 /M DNA checkpoint is at least partially mediated by phosphorylation of serine 216 in Cdc25C (13, 14) . To study the role of serine 216 in this checkpoint, we raised an antibody to a phosphopeptide surrounding the serine 216 phosphorylation site. To test the specificity of the antibody, we performed an in vitro assay using GST-Chk2 as the active kinase and GST-Cdc25C as the substrate. A kinase-dead Chk2 fusion protein (D347A) was included as a negative control. The assay mixture was resolved on 10% SDS-PAGE and blotted with anti phospho-S216 antibody. As shown in the Western blot (Fig. 1A, lane 3) , the phospho-S216 antibody recognized Cdc25C that was incubated with a wild type Chk2 in the in vitro kinase assay but failed to recognize unphosphorylated Cdc25C, incubated with a kinase-dead mutant (D347A) (Fig.  1A, lane 2) . Moreover, a peptide surrounding serine 216 blocked the antibody recognition (data not shown). These findings indicate that the anti-phospho-S216 antibody recognizes Cdc25C specifically when it is phosphorylated at serine 216 and confirms that Chk2/Cds1 phosphorylates Cdc25C at serine 216 in vitro. To determine the intracellular localization of serine 216-phosphorylated Cdc25C and the effect of DNA damage checkpoint activation on serine 216 phosphorylation, biochemical fractionation experiments were performed using asynchronously growing MRC-5 cells before and immediately after IR with or without prior treatment of cells with caffeine. Wholecell, cytoplasmic, or nuclear extracts were prepared as described under "Experimental Procedures." Equal amounts of protein in each sample were resolved on 10% SDS-PAGE, transferred to membranes, and blotted with anti-phospho-S216 and anti-Cdc25c antibody, respectively. Serine 216-phosphorylated Cdc25C was detected predominantly in the cytoplasmic extracts and to a lesser extent in the nuclear fraction (Fig. 1B,  lanes 1 and 5) . As a control for biochemical fractionation, nuclear protein nucleolin was found to be localized in the nuclear fractions (data not shown). Immediately after IR, an increase in serine 216-phosphorylated Cdc25C was observed in the nuclear fraction (Fig. 1B, lane 2) , and prior treatment of cells with caffeine inhibited this increase (Fig. 1B, lane 4) . On the other hand, there was no appreciable increase in serine 216 phosphorylation in whole cell lysates (data not shown), consistent with the observation that the majority of serine 216-phosphorylated Cdc25C is in the cytoplasm (Fig. 1B, lane 5) . Caffeine alone did not alter serine 216 phosphorylation in the absence of IR (Fig.  1B, lane 3) . Cdc25C was partitioned between nuclear and cytoplasmic fractions similarly to serine 216-phosphorylated Cdc25C. No gross relocation of Cdc25C was observed immediately after IR (Fig. 1B, lanes 2 and 6) . Our data support a model that an increase in serine 216 phosphorylation in the nucleus is caused by the activation of serine 216 kinase but cannot totally rule out the possibility of nuclear relocation of Cdc25C as an alternative mechanism. This finding implies that caffeine could inhibit the activation of the serine 216 kinase in the nucleus after IR at a concentration at which it can abrogate the G 2 /M checkpoint.
To confirm the cellular localization of phosphorylated Cdc25C after IR, indirect immunofluoresence analysis of normal diploid human fibroblasts (MRC-5) was performed. Actively proliferating cells were ␥-irradiated and allowed to recover for 30 min at 37°C before immunostaining. As a negative control, cells were left untreated or unirradiated. As shown in Fig. 2 , punctate staining for serine 216 was obtained; in contrast to the results of biochemical fractionation experiments (Fig. 1B) , serine 216 staining was found to be enriched in the nucleus of both irradiated and unirradiated samples. Cytoplasmic staining was diminished in all the samples. This can be explained by the fact that phosphorylated serine 216 epitope is perhaps not exposed in the cytoplasm due to interaction with 14-3-3 proteins as has been reported previously (13, 14) . We observed a possible increase in nuclear serine 216 reactivity after IR treatment of cells as these cells stained brighter than the unirradiated cells (Fig. 2) .
To determine whether the increase in serine 216 phosphorylation observed after radiation is ATM-dependent, we repeated the biochemical fractionation experiment using the A-T cell line AGO4405. No change in anti-phospho-S216 staining was observed in AGO4405 cells after IR exposure (Fig. 1C,  lanes 1 and 2) , and caffeine had no effect in the A-T cells (Fig.  1C, lanes 3 and 4) . These results demonstrate that radiationinduced phosphorylation of Cdc25C on serine 216 in the nucleus is dependent on ATM and is inhibited by caffeine.
Caffeine Inhibits Chk2/Cds1 Activation in an ATM-dependent Manner-Which serine 216 kinase does caffeine affect in the nucleus? Both Chk1 and Chk2/Cds1 have been shown to localize to the nucleus and to phosphorylate serine 216 of Cdc25C in vitro (13, 15) (18 -21) . Although the phosphorylation state of Chk1 is altered in response to DNA damage (15), it does not correspond to an increase in its kinase activity toward Cdc25C. 2 It is still unclear whether Cdc25C is a substrate for Chk1 in vivo. On the other hand, Chk2/Cds1 kinase activity toward Cdc25C increases substantially after IR in an ATM-dependent manner (18 -21) . To test the possibility that Chk2/ Cds1 is a target for caffeine in abrogating the G 2 /M checkpoint, we determined whether ATM-dependent Chk2/Cds1 activation is inhibited by caffeine. Immunoprecipitate kinase assays were performed using total lysates prepared from normal (MRC-5) and A-T (AGO4405) cells treated with caffeine and then irradiated with 20 Gy of radiation using GST-Cdc25C as a substrate (21) . Lysates from cells that were untreated, treated with caffeine alone, and ␥-irradiated alone were included in the assay as controls. As shown in Fig. 3A in normal cells, IR causes activation of Chk2/Cds1 (lane 2), and this activation is inhibited by prior treatment of cells with caffeine (lane 4). However, no such activation was found in A-T cells indicating that caffeine inhibited the ATM-dependent Chk2/Cds1 activation (Fig. 3A, lanes 6 and 8) . The Chk2 activity was also 2 K. K. Khanna, S. Kozlov, and B. Gabrielli, unpublished results. measured by an immunoassay using anti-phospho-S216 antibody (Fig. 3B) . Reaction mixtures identical to those used in the radioactive kinase assay were analyzed on 10% SDS-PAGE, transferred onto nitrocellulose membrane, and blotted with anti-phospho-S216. Serine 216 phosphorylation activity of Chk2 was clearly increased in response to DNA damage (Fig.  3B, lane 2) , and the increase was prevented by prior treatment of cells with caffeine (Fig. 3B, lane 4) . Again no effect of caffeine was found in A-T cells (Fig. 3B, lane 8) . To examine whether Chk2/Cds1 is a direct target of caffeine, an in vitro kinase assay was performed with recombinant Chk2 using GST-Cdc25C as a substrate in the presence or absence of increasing concentrations of caffeine. A kinase-dead mutant of Chk2 (D347A) was included as a negative control in the assay. Caffeine did not inhibit the kinase activity of Chk2 even at a concentration of 2 mM (Fig. 3C) suggesting that Chk2 is not a direct target; instead, caffeine might inhibit either ATM kinase activity or the pathway leading to Chk2/Cds1 activation.
ATM Phosphorylates Chk2/Cds1 in Vitro-Chk2/Cds1 activation after IR has been shown to depend on ATM kinase activity (18 -21) . To test the possibility that ATM can phosphorylate Chk2/Cds1 directly, active ATM was immunoprecipitated from normal human lymphoblastoid C3ABR cells that had been either ␥-irradiated or mock-treated. ATM nonexpressing human A-T lymphoblast (L3) cells were used as a negative control. Because wild type Chk2 has a high level of autophosphorylation activity (data not shown), kinase-dead Chk2 mutant (D347A) was used as the substrate in the ATM kinase assay. As shown in Fig. 4A , ATM immunoprecipitated from C3ABR phosphorylated Chk2/Cds1 directly, and ATM activity increased by approximately 4-fold after radiation. In negative control A-T cells (L3), there is only background phosphorylation of Chk2. To analyze the location of phosphorylation, we expressed Chk2 as two separate domains: the Nterminal domain, containing amino acids 1-222; and the C-terminal domain (with D347A mutation to inactivate kinase activity), containing amino acids 206 -543. As shown in Fig. 4A , most of the phosphorylation was in the N-terminal domain; there was very little in the C-terminal domain (D347A). Similarly constructed wild type C-terminal domain is kinase-active (data not shown), indicating that misfolding is not a cause of the lack of phosphorylation. Analysis of the Chk2/Cds1 sequence within this region revealed a cluster of serines (S) and threonines (T) followed by glutamine (Q) (SQ or TQ). SQ or TQ sequences are the preferred sites of ATM phosphorylation on p53 and c-Abl (27) (28) (29) . Among different SQ and TQ sites in the N-terminal of Chk2/Cds1, the sequence around threonine 68 (STQE) is the closest to the preferred ATM phosphorylation sites on p53 (LSQE) and c-Abl (LSQV) (27) (28) (29) , suggesting threonine 68 as a possible site for ATM phosphorylation in Chk2/Cds1. Substitution of threonine 68 by alanine in the full-length kinase-dead Chk2 dramatically reduced but did not abolish the ATM phosphorylation of Chk2/Cds1 in vitro ( Fig.  4B ; threonine 68 accounts for approximately 70% of the total phosphorylation). To confirm that threonine 68 of Chk2/Cds1 is the site of ATM phosphorylation in vitro and to study its role in vivo, we raised antibodies to a phosphopeptide surrounding the phosphorylation site. To test the specificity of the antibody, we performed an in vitro assay using immunoprecipitated ATM as kinase and kinase-dead GST-Chk2 as substrate. As shown in the Western blot (Fig. 4C) , the phospho-T68 antibody recognized Chk2 that was incubated with immunoprecipitated ATM The cell lysates were immunoprecipitated with anti-Chk2 antibody, and kinase assays were performed using GST-Cdc25C as a substrate. The reaction mixtures were resolved by SDS-PAGE, and the 32 P-labeled GST-Cdc25C were visualized by autoradiography. The relative Chk2 activities are shown graphically. B, the same reaction mixtures as in A were resolved by SDS-PAGE, and the phosphorylated GST-Cdc25C was detected by serine 216 phospho-specific antibody. C, caffeine did not inhibit Chk2 directly. Purified recombinant GST-Chk2 (ϩ) or negative control (Ϫ or KD) were incubated with GST-Cdc25C at increasing amounts of caffeine. The reaction mixture were resolved by SDS-PAGE, and the 32 P-labeled GST-Cdc25C were visualized by autoradiography. Inactive GST-Chk2 (D347A) (KD) was used as a negative control.
FIG. 4. ATM phosphorylates Chk2 directly in vitro.
A, immunoprecipitated ATM from C3ABR cells (normal) and L3 cells (A-T) before or after ␥-radiation (IR) were incubated with purified GST-Chk2 (D347A) (KD), GST-Chk2-N-terminal (amino acids 1-222), and GSTChk2-C-terminal (D347A) (amino acids 206 -543) in the kinase assay. B, immunoprecipitated ATM from C3ABR cells before or after ␥-radiation (IR) were incubated with purified kinase-dead (KD) GST-Chk2 (Control) and threonine 68 to alanine mutant (T68A) in the kinase assay. C, the same reaction mixtures show in A using GST-Chk2 (D347A) (KD) were probed with anti-phospho-T68 antibody.
in the kinase assay but failed to recognize unphosphorylated Chk2. These findings indicate that the anti-phospho-T68 specifically recognizes Chk2 when it is phosphorylated at threonine 68 and confirm that ATM phosphorylates Chk2 at threonine 68 in vitro.
Caffeine Inhibits ATM-dependent Chk2 Phosphorylation in Cells and ATM Phosphorylation of Purified Recombinant
Chk2-It is possible that ATM is also an in vivo kinase for Chk2 and that caffeine inhibits Chk2 activation by inhibiting ATM kinase activity. To test whether caffeine can inhibit the ATM-dependent Chk2 phosphorylation in cells, Western blots were generated using extracts made from both normal cells (MRC-5) and AT cells (AGO4405) before and after ␥-irradiation with or without prior treatment with caffeine. Equal amounts of protein in each sample were separated by 10% SDS-PAGE, and the gels were transferred and blotted with anti-Chk2 antibody. Fig. 5A shows that even though the levels of Chk2 in all samples were comparable, the migration of Chk2 protein from ␥-irradiated cells was slower (lane 2) than that in the control (lane 1); in cells treated with caffeine prior to ␥-irradiation, however, the mobility shift was not observed (lane 4). The change in mobility is attributed to the phosphorylation of Chk2 in an ATM-dependent manner (18 -21) , and thus prior treatment with caffeine inhibits this ATM-dependent phosphorylation. Because threonine 68 of Chk2 is the ATM phosphorylation site in vitro, we utilized anti-phospho-T68 antibody to determine whether threonine 68 was phosphorylated upon ATM activation in response to ␥-radiation, and whether this phosphorylation could be inhibited by caffeine. Due to nonspecific contaminating bands in the cytoplasm recognized by anti-phospho-T68 (data not shown), nuclear extracts of cells treated as in Fig. 5A were used for immunoblotting. As shown in Fig. 5B , immediately after ␥-irradiation, the amount of threonine 68-phosphorylated Chk2 increased (lane 2), and prior treatment of cells with caffeine markedly reduced this increase (lane 4). There is still a slight increase in threonine 68 phosphorylation in IR and caffeine-treated sample (Fig. 5B, lane 4) , which failed to show a mobility shift (Fig. 5A) , implying that other phosphorylation sites could be also involved in the shift. These results support a model in which ATM is the kinase that phosphorylates Chk2/Cds1 in cells in response to DNA damage, and caffeine inhibits the Chk2/Cds1 activation by inhibiting ATM kinase activity.
To see whether caffeine can inhibit ATM phosphorylation of Chk2 directly, the ATM kinase reaction was performed in the presence of various concentrations of caffeine. Active ATM was immunoprecipitated from normal human lymphoblastoid C3ABR cells that were either ␥-irradiated or mock-treated, and kinase-dead Chk2 mutant (D347A) was used as the substrate in the ATM kinase assay. As shown in Fig. 6A , ATM immunoprecipitated from irradiated cells was more active than that from unirradiated cells, and both the basal and radiationinduced ATM activities were inhibited by caffeine with an IC 50 at around 200 M. The ATM activity was also measured by an immunoassay using anti-phospho-T68 antibody (Fig. 6B) . The same reaction mixture as in the radioactive kinase assay was analyzed on 10% SDS-PAGE, transferred onto nitrocellulose membrane, and blotted with anti-phospho-T68. As shown in Fig. 6B , threonine 68 phosphorylation activity of ATM was also inhibited by caffeine with similar IC 50 as that measured by the radioactive kinase assay. Because caffeine induces radiosensitization and inhibits checkpoint functions at concentrations of 0.5 to 5 mM, the results of the in vitro kinase assay suggest that ATM is a relevant target for caffeine in intact cells.
Caffeine Inhibits ATM Phosphorylation of p53 Both in Vitro and in Vivo-Recent studies have suggested that ATM is also the in vivo kinase phosphorylating p53 on serine 15 at short times after exposure of cells to ␥-radiation (27, 29, 30) . To confirm that ATM is a direct target of caffeine, we initially determined whether caffeine could inhibit ATM phosphorylation of p53 in vitro. Immunoprecipitated ATM was incubated with the purified N-terminal fragment of p53 (amino acids 1-40) in the kinase reaction in the presence of increasing concentrations of caffeine. Serine 15 in the N terminus of p53 has been shown to be the preferred ATM phosphorylation site (27, 29, 30) . As shown in Fig. 7A , ATM immunoprecipitated from irradiated cells was more active than that from control cells, and both ATM activities were inhibited by caffeine with IC 50 at around 200 M. To determine whether caffeine inhibits ATM phosphorylation of p53 on serine 15 in vivo, Western blot experiments using anti-phosphoserine 15 were performed on extracts made from C3ABR cells before and after ␥-irradiation with or without prior treatment with caffeine. As shown in Fig.  7B , there is a dramatic increase in serine 15 phosphorylated p53 after radiation (Lane 2), which is markedly reduced by prior treatment with caffeine (Lane 4). These results suggested that ATM phosphorylation of p53 can be inhibited by caffeine, consistent with the hypothesis that ATM is the molecular target of caffeine. DISCUSSION Although caffeine has been a useful tool in discerning the existence of DNA damage checkpoints, the underlying mechanism is not clear. The ability of caffeine to block radiationinduced G 2 arrest suggests that it targets one of the proteins involved in the activation of the G 2 /M checkpoint. In this communication, we provide evidence that the ability of caffeine to abrogate the checkpoint is correlated with its ability to inhibit the radiation-induced increase in Cdc25C serine 216 phosphorylation in the nucleus, probably through inhibiting the ATMChk2/Cds1 pathway. On the basis of the profound radiation sensitivity of ATM-deficient cells, these results suggest that inhibition of ATM by caffeine is responsible for the radiosensitizing effects of this compound.
Although the G 2 /M DNA checkpoint is believed to be at least partially mediated by phosphorylation of serine 216 in Cdc25C (13, 14) , the detailed mechanism remains unclear, and it has been difficult to detect an effect of DNA damage such as that produced by ionizing radiation on serine 216 phosphorylation. To overcome these technical difficulties, we raised an antibody to a phosphopeptide surrounding the serine 216 phosphorylation site in Cdc25C and found it to be phospho-specific. Using anti-phospho-S216 antibody, caffeine-sensitive increases in serine 216-phosphorylated Cdc25C were observed in the nuclear fraction immediately after IR. Indirect immunofluoresence analysis confirmed this finding. The observed increase in serine 216 phosphorylation could be a transient event. It will be of interest to explore this result further, e.g. by studying the kinetics of the IR-induced increase in serine 216-phosphorylated Cdc25C in the nucleus and seeing whether translocation of Cdc25C from the nucleus to cytoplasm follows such phosphorylation. Because no obvious relocation of Cdc25C into the nucleus was observed immediately after irradiation, our results are consistent with a hypothesis that one or more nuclear serine 216 kinases is activated after DNA damage (13, 15) (18 -21), and caffeine targets the pathway that leads to kinase activation.
In response to DNA damage and DNA replication block, Chk1 and Chk2/Cds1 have been implicated in phosphorylation of Cdc25C at serine 216 to prevent entry into mitosis (13, 15, 18 -21) . It is still not clear whether both Chk1 and Chk2/Cds1 kinases are required to prevent mitosis by inhibiting Cdc25C or whether in the absence of one the other is sufficient for this function. Although both Chk1 and Chk2/Cds1 are phosphorylated in response to radiation, only the kinase activity of Chk2/ Cds1 has been shown to increase after DNA damage (18 -21) . From the immunoprecipitate kinase studies (Fig. 3) , it is evident that caffeine can inhibit ATM-dependent Chk2/Cds1 activation because there was a significant reduction in the kinase activity phosphorylating Cdc25C at serine 216 in normal cells (ATMϩ) treated with caffeine. This reduction in phosphorylation and activation was not found in AT cells, thus indicating that the ATM-Chk2/Cds1 pathway is one likely target of caffeine in abrogating the G 2 /M checkpoint. Nevertheless, our results do not exclude the possibility that the Chk1 pathway is also sensitive to the effects of caffeine on the DNA damage checkpoint.
ATM-dependent Chk2/Cds1 activation has been suggested to be correlated with the ATM-dependent phosphorylation of Chk2/Cds1 (18 -21) . The experiments reported here show that ATM phosphorylates Chk2/Cds1 directly in the N-terminal region in vitro, and threonine 68 is one major phosphorylation site (Fig. 5) . At this point, we do not have evidence that ATM phosphorylation of Chk2/Cds1 is sufficient for its activation. In vivo, threonine 68 can be phosphorylated in response to IR in an ATM-dependent manner. These results suggest that ATM is a direct kinase for Chk2/Cds1. In vitro, caffeine can inhibit Chk2 phosphorylation by ATM at an IC 50 of 200 M. Our in vivo studies (Fig. 6 ) also show that caffeine can inhibit phosphorylation of p53, known to be an important substrate of ATM (27, 29, 30) . Furthermore, in various assays including serine 216 phosphorylation, Chk2/Cds1 phosphorylation, and activation, caffeine-treated cells behave the same as A-T cells. These results support a model (Fig. 8 ) in which caffeine prevents the activation of Chk2/Cds1 by inhibiting ATM, which in turn prevents the serine 216 phosphorylation and inactivation of Cdc25C in the nucleus, likely through 14-3-3-mediated translocation (13, 14) . The observation that ATM is the molecular target of caffeine strengthens the hypothesis that inhibiting ATM or Chk2/Cds1 will sensitize repair-proficient cancer cells to radiation therapy and chemotherapy. Recent observations that p53-deficient cells are preferentially sensitized to radiation-induced killing by caffeine (31) (32) (33) suggest that targeting the ATM pathway might even introduce selectivity to current cancer therapy. The development of potent and selective inhibitors for ATM will provide the means to test this hypothesis.
